Healthcare provider profile · identity verified

Joseph David Augustin, FNP

Nurse Practitioner · PORTSMOUTH, OH · NPI 1053759456

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	286	87
Amlodipine Besylate	Amlodipine Besylate	255	66
Levothyroxine Sodium	Levothyroxine Sodium	255	62
Albuterol Sulfate Hfa	Albuterol Sulfate	248	67
Pantoprazole Sodium	Pantoprazole Sodium	210	54
Gabapentin	Gabapentin	195	35
Metformin Hcl Er	Metformin Hcl	186	37
Ozempic	Semaglutide	172	28
Montelukast Sodium	Montelukast Sodium	167	39
Potassium Chloride	Potassium Chloride	159	39
Losartan Potassium	Losartan Potassium	149	40
Lisinopril	Lisinopril	142	41
Omeprazole	Omeprazole	141	33
Trazodone Hcl	Trazodone Hcl	132	28
Trulicity	Dulaglutide	126	18
Ropinirole Hcl	Ropinirole Hcl	120	16
Fluticasone Propionate	Fluticasone Propionate	119	43
Metoprolol Succinate	Metoprolol Succinate	111	35
Mounjaro	Tirzepatide	110	16
Diclofenac Sodium	Diclofenac Sodium	96	20
Sertraline Hcl	Sertraline Hcl	94	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	92	20
Famotidine	Famotidine	83	23
Furosemide	Furosemide	81	26
Tramadol Hcl	Tramadol Hcl	80	16
Hydroxyzine Hcl	Hydroxyzine Hcl	79	suppressed
Metformin Hcl	Metformin Hcl	79	23
Pioglitazone Hcl	Pioglitazone Hcl	79	19
Hydrochlorothiazide	Hydrochlorothiazide	78	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	17
Tizanidine Hcl	Tizanidine Hcl	73	14
Lorazepam	Lorazepam	72	13
Tamsulosin Hcl	Tamsulosin Hcl	72	23
Metoprolol Tartrate	Metoprolol Tartrate	71	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	11
Spironolactone	Spironolactone	59	14
Ibuprofen	Ibuprofen	58	15
Duloxetine Hcl	Duloxetine Hcl	55	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	55	16
Carvedilol	Carvedilol	53	17
Meloxicam	Meloxicam	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	15
Simvastatin	Simvastatin	48	12
Alprazolam	Alprazolam	47	suppressed
Farxiga	Dapagliflozin Propanediol	47	suppressed
Pregabalin	Pregabalin	45	suppressed
Breo Ellipta	Fluticasone/Vilanterol	42	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	42	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Methocarbamol	Methocarbamol	40	11
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Methylprednisolone	Methylprednisolone	39	30
Ondansetron Odt	Ondansetron	39	16
Buspirone Hcl	Buspirone Hcl	38	suppressed
Celecoxib	Celecoxib	38	12
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	37	suppressed
Topiramate	Topiramate	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Ventolin Hfa	Albuterol Sulfate	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Tresiba Flextouch U-100	Insulin Degludec	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Linzess	Linaclotide	29	suppressed
Prednisone	Prednisone	29	24
Allopurinol	Allopurinol	27	suppressed
Azithromycin	Azithromycin	27	25
Bupropion Xl	Bupropion Hcl	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	25	11
Vascepa	Icosapent Ethyl	25	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	24	suppressed
Diazepam	Diazepam	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Eliquis	Apixaban	22	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Baclofen	Baclofen	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Glipizide	Glipizide	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Clonidine Hcl	Clonidine Hcl	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Naproxen	Naproxen	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nexium	Esomeprazole Magnesium	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Ibu	Ibuprofen	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Theophylline Er	Theophylline Anhydrous	13	suppressed
Atenolol	Atenolol	12	suppressed
Colchicine	Colchicine	12	suppressed
Fluconazole	Fluconazole	12	11
Rexulti	Brexpiprazole	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error